Researchers at Kameda Medical Center Have Published New Data on Breast Cancer (Cryoablation as the primary treatment in a HER2 positive Stage IV breast cancer patient: 5 years term follow up case report).

A recent report from Kameda Medical Center in Chiba, Japan, discusses the case of a 34-year-old woman with stage IV breast cancer and metastatic lung cancer who was treated with cryoablation as a first-line treatment. The patient received chemotherapy and targeted therapy before undergoing minimally invasive cryoablation and radiation therapy. After five years of follow-up, the patient showed a complete local response with no evidence of disease progression. The researchers concluded that cryoablation can be a safe and effective treatment option for stage IV breast cancer, preserving quality of life and offering favorable cosmetic results. [Extracted from the article]